Skip to main content
. 2021 Apr 29;10(1):810–821. doi: 10.1080/22221751.2021.1917309

Figure 1.

Figure 1.

Cross-inhibitory activity of coronavirus fusion inhibitors against HIV-1. (A) Inhibition of EK1 and EK1V1 on HIV-1NL4-3 Env-mediated cell–cell fusion was determined by a dual-split protein (DSP)-based cell fusion assay. The inhibitory activities of EK1 and EK1V1 against the pseudoviruses of HIV-1NL4-3 (B), H5N1 (C), H7N9 (D), RSV (E), and VSV (F), were determined by a single-cycle infection assay. Both the cell fusion and pseudovirus infection assays were repeated at least three times, and data are expressed as means ± standard deviations (SD) while the mean IC50 values are shown.